Hand, foot, and mouth disease (HFMD) is spreading rapidly among infants and young children in Korea.According to sentinel ...

Daewoong has selected U.S. private equity firm TA Associates as the new preferred bidder to acquire control of CGBio after ...

The Korean Medical Association (KMA) plans to propose that the government enact a special law governing the use of artificial ...

Oscotec Inc. has unveiled a strategy to expand its next-generation pipeline centered on its anti-resistance cancer drug ...

As Korea enters a super-aged society, the need to manage patients with mild cognitive impairment (MCI) and individuals at ...

Hanmi Pharmaceutical said Friday that its domestic phase 2 clinical trial of belvarafenib, an oral targeted anticancer drug ...

A Seoul court has ruled in favor of 139 patients who sued Kolon Life Science and Kolon TissueGene over Invossa-K, an ...

A Korean research team has uncovered a key genetic mechanism that determines whether cells survive or undergo programmed cell ...

GC Biopharma and Korea Vaccine have signed a memorandum of understanding to collaborate on vaccine contract manufacturing, ...

Ybrain said Friday it has signed a domestic co-business agreement with Korea Pharma covering the distribution and sales of ...

Celltrion’s high-margin follow-up biosimilar portfolio continues to gain market share across Europe, reinforcing the ...

GC Cell said Thursday that its immune cell therapy, Immunecell-LC Injection, has been officially accepted into the World ...